Position in JNJ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$401,494,898
-$92,167,562 QoQ
Shares Held
1,642,509
-31.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $4,969,350,861 across 12 Drug Manufacturers - General names. JNJ ranks #4 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,624,427 | $1,503,689,491 | |
| 2 | LLY |
ELI LILLY & Co
|
1,157,476 | $1,064,611,698 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,423,414 | $616,491,207 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
1,642,509 | $401,494,898 | |
| 5 | ABBV |
AbbVie Inc.
|
1,491,841 | $324,460,498 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,316,095 | $278,603,066 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,407,916 | $267,340,104 | |
| 8 | AMGN |
Amgen Inc
|
741,006 | $260,722,960 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $401,494,898 | 1,642,509 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $493,662,460 | 2,385,419 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $102,336,264 | 551,916 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $68,785,769 | 450,316 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $84,976,250 | 512,399 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $55,467,844 | 383,542 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $43,403,881 | 267,826 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $78,232,432 | 535,252 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $70,209,309 | 443,829 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $92,097,916 | 587,584 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $107,126,874 | 687,813 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $96,577,444 | 583,479 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $74,570,965 | 481,103 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $89,120,454 | 504,503 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $63,571,707 | 389,151 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $116,792,880 | 657,951 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $102,222,010 | 576,776 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $99,886,746 | 583,894 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $100,643,085 | 623,177 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $63,566,905 | 385,862 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $63,886,953 | 388,725 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $48,911,972 | 310,789 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $40,437,743 | 271,613 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $13,016,572 | 92,559 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $12,642,243 | 96,410 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||